← all drugs
Sufentanil Citrate Injection
in shortage · Analgesia/Addiction · Snapshot: 2026-10-09
Day 1,620
of this shortage, counting from the FDA's first posting on 05/03/2022
- Manufacturers listed
- Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company
- Reported reason(s)
- Other
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
| Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02) | Hikma Pharmaceuticals USA, Inc. | Unavailable | 09/18/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-09-15 — Sufentanil Citrate Injection: availability wording revised for 1 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.